Mimedx (MDXG) Capital Expenditures (QoQ) (2011 - 2026)
Mimedx (MDXG) Capital Expenditures (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.00% |
| Dec 31, 2025 | 48.44% |
| Sep 30, 2025 | 7.26% |
| Jun 30, 2025 | -52.52% |
| Mar 31, 2025 | 43.35% |
| Dec 31, 2024 | 53.80% |
| Sep 30, 2024 | 62.86% |
| Jun 30, 2024 | -90.82% |
| Mar 31, 2024 | -42.43% |
| Dec 31, 2023 | 313.20% |
| Sep 30, 2023 | -200.00% |
| Dec 31, 2022 | 91.12% |
| Sep 30, 2022 | -8.16% |
| Jun 30, 2022 | 222.03% |
| Mar 31, 2022 | -63.69% |
| Dec 31, 2021 | -40.59% |
| Sep 30, 2021 | 35.06% |
| Jun 30, 2021 | -79.13% |
| Mar 31, 2021 | -9.93% |
| Dec 31, 2020 | 230.52% |